Drug Development Institute
Research - Columbus, Ohio, United States
Drug Development Institute Employees
Chad Bennett
Sr. Director of Chemistry â Drug Development Inst., Co-Dir. â Medicinal Chemistry Shared Resource
Drug Development Institute Details
The Drug Development Institute (DDI) is a biotech-like institute embedded in The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). By bringing an industry-focused perspective to all investment and management decisions, the DDI ensures that programs have a high likelihood of progressing to clinical stage development. Our goal is to rapidly translate Ohio State's most innovative research into tomorrow's most promising treatments for patients with cancer.The DDI employs a combination of targeted investments, strategic management and cutting-edge drug development resources to drive projects from discovery through early drug development, thus creating high-value new drug candidates.The DDI Pipeline:Research: The DDI leverages world-class research and drug development resources at The Ohio State University to advance projects from early drug discovery through preclinical and clinical development.Advisory Board: The DDI Advisory Board consists of internationally recognized experts with proven track records in pharmaceutical drug discovery, development and commercialization.Partnerships with Industry and Venture Capitalist Firms: DDI partners with pharmaceutical, biotech and venture capital companies to bridge the gap between drug discovery and early clinical development, accelerating development timelines and delivering innovative treatments to patients sooner.
